In the present study, we have demonstrated that gene deletion or pharmacological blockade of KCa3.1 with senicapoc results in improved locomotor ability and the TH-positive neuron number and attenuates the microglial activation and neuroinflammation in the SNpc of MPTP-induced PD mouse model. Here, KCNN4 is linked to Parkinson disease.